{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:43Z","timestamp":1787026603331,"version":"build-2736575974"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00464","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T07:53:28Z","timestamp":1597996408000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Nevena","family":"Zubcevik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer L.","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Nadlyne","family":"Octavien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","article-title":"The pathogenesis of Lyme neuroborreliosis: from infection to inflammation","volume":"14","author":"Rupprecht","year":"2008","journal-title":"Mol Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0198509","DOI":"10.1371\/journal.pone.0198509","article-title":"Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014","volume":"13","author":"Johnson","year":"2018","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1542\/peds.96.6.1053","article-title":"Neurologic manifestations in children with Lyme disease","volume":"96","author":"Bingham","year":"1995","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S1475","DOI":"10.1093\/clinids\/11.Supplement_6.S1475","article-title":"Dermatologic manifestations of Lyme disease","volume":"11","author":"Berger","year":"1989","journal-title":"Rev Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.4081\/or.2011.e14","article-title":"Misdiagnosis of early Lyme disease as the summer flu","volume":"3","author":"Aucott","year":"2011","journal-title":"Orthop Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jama.1992.03480100070033","article-title":"Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection","volume":"267","author":"Luft","year":"1992","journal-title":"JAMA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0176-6724(87)80081-0","article-title":"CNS manifestations of third stage Lyme disease","volume":"263","author":"Pachner","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00415-013-6831-4","article-title":"Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life","volume":"260","author":"Back","year":"2013","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejpn.2017.10.010","article-title":"Pediatric stroke related to Lyme neuroborreliosis: data from the swiss neuropaediatric stroke registry and literature review","volume":"22","author":"Monteventi","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/qjmed\/hcv043","article-title":"On the radar: Lyme neuroborreliosis, an infectious cause of cerebral vasculitis","volume":"108","author":"Pearson","year":"2015","journal-title":"QJM."},{"key":"B15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.056","article-title":"Cerebrovascular events in Lyme neuroborreliosis","volume":"24","author":"Wittwer","year":"2015","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med."},{"key":"B22","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10-20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","article-title":"Risk factors for a non-favorable outcome after treated European neuroborreliosis","volume":"127","author":"Eikeland","year":"2013","journal-title":"Acta Neurol Scand."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0189071","DOI":"10.1371\/journal.pone.0189071","article-title":"Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to borrelia burgdorferi by tick feeding","volume":"12","author":"Embers","year":"2017","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ajpath.2017.11.005","article-title":"Late disseminated Lyme disease: associated pathology and spirochete persistence posttreatment in rhesus macaques","volume":"188","author":"Crossland","year":"2018","journal-title":"Am J Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1038\/emi.2014.53","article-title":"Identification of novel activity against borrelia burgdorferi persisters using an FDA approved drug library","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg Microbes Infect."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e86907","DOI":"10.1371\/journal.pone.0086907","article-title":"Resurgence of persisting non-cultivable borrelia burgdorferi following antibiotic treatment in mice","volume":"9","author":"Hodzic","year":"2014","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.medmal.2008.11.012","article-title":"Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS)","volume":"39","author":"Clarissou","year":"2009","journal-title":"Med Mal Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to Lyme disease","volume":"374","author":"Berende","year":"2016","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.lpm.2015.06.002","article-title":"Critical review of studies trying to evaluate the treatment of chronic Lyme disease","volume":"44","author":"Perronne","year":"2015","journal-title":"Presse Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","article-title":"Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials","volume":"33","author":"Delong","year":"2012","journal-title":"Contemp Clin Trials."},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874205X01206010079","article-title":"A reappraisal of the u.s. Clinical trials of post-treatment Lyme disease syndrome","volume":"6","author":"Fallon","year":"2012","journal-title":"Open Neurol J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0212222","DOI":"10.1371\/journal.pone.0212222","article-title":"Association of small fiber neuropathy and post treatment Lyme disease syndrome","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12974-018-1381-4","article-title":"Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [(11)C]DPA-713 PET","volume":"15","author":"Coughlin","year":"2018","journal-title":"J Neuroinflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2353\/ajpath.2008.080483","article-title":"Interaction of the Lyme disease spirochete borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis","volume":"173","author":"Ramesh","year":"2008","journal-title":"Am J Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-6-23","article-title":"Possible role of glial cells in the onset and progression of Lyme neuroborreliosis","volume":"6","author":"Ramesh","year":"2009","journal-title":"J Neuroinflamm."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ajpath.2015.01.024","article-title":"Inflammation in the pathogenesis of Lyme neuroborreliosis","volume":"185","author":"Ramesh","year":"2015","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2005.04.069","article-title":"Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to borrelia burgdorferi lipoproteins","volume":"384","author":"Ramesh","year":"2005","journal-title":"Neurosci Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1742-2094-10-88","article-title":"The Lyme disease spirochete borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia","volume":"10","author":"Ramesh","year":"2013","journal-title":"J Neuroinflamm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.soncn.2016.08.004","article-title":"Cancer symptom cluster management","volume":"32","author":"Kwekkeboom","year":"2016","journal-title":"Semin Oncol Nurs."},{"key":"B50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jgo.2018.05.002","article-title":"Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: the mediating role of subjective stress","volume":"9","author":"Levkovich","year":"2018","journal-title":"J Geriatr Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jpainsymman.2018.01.008","article-title":"The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer","volume":"55","author":"Kwekkeboom","year":"2018","journal-title":"J Pain Symptom Manage."},{"key":"B52","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nur.21813","article-title":"Symptom clusters in adults with inflammatory bowel disease","volume":"40","author":"Conley","year":"2017","journal-title":"Res Nurs Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4187\/respcare.05374","article-title":"Symptom clusters and quality of life in subjects with COPD","volume":"62","author":"Lim","year":"2017","journal-title":"Respir Care."},{"key":"B54","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11136-014-0804-7","article-title":"Contribution of symptom clusters to multiple sclerosis consequences","volume":"24","author":"Shahrbanian","year":"2015","journal-title":"Qual Life Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/pon.4883","article-title":"Randomized controlled trial of a brief cognitive-behavioral strategies intervention for the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer","volume":"27","author":"Kwekkeboom","year":"2018","journal-title":"Psychooncology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/SPC.0b013e32835dabe3","article-title":"Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster","volume":"7","author":"Wood","year":"2013","journal-title":"Curr Opin Support Palliat Care."},{"key":"B57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fmed.2019.00283","article-title":"The general symptom questionnaire-30 (gsq-30): a brief measure of multi-system symptom burden in Lyme disease","volume":"6","author":"Fallon","year":"2019","journal-title":"Front Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hup.2500","article-title":"Assessment of functional outcomes by sheehan disability scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors","volume":"31","author":"Sheehan","year":"2016","journal-title":"Hum Psychopharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jpainsymman.2017.04.005","article-title":"Differences in symptom clusters identified using ratings of symptom occurrence vs. Severity in lung cancer patients receiving chemotherapy","volume":"54","author":"Wong","year":"2017","journal-title":"J Pain Symptom Manage."},{"key":"B60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpainsymman.2019.10.002","article-title":"Symptom clusters in women with breast cancer during the first 18 months of adjuvant therapy","volume":"59","author":"Li","year":"2019","journal-title":"J Pain Symptom Manage."},{"key":"B61","doi-asserted-by":"publisher","first-page":"zsy035","DOI":"10.1093\/sleep\/zsy035","article-title":"Sleep quality in well-defined Lyme disease: a clinical cohort study in maryland","volume":"41","author":"Weinstein","year":"2018","journal-title":"Sleep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpainsymman.2017.08.008","article-title":"Stability of symptom clusters in patients with breast cancer receiving chemotherapy","volume":"55","author":"Sullivan","year":"2018","journal-title":"J Pain Symptom Manage."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1111\/jocn.15047","article-title":"Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy","volume":"28","author":"Li","year":"2019","journal-title":"J Clin Nurs."},{"key":"B64","doi-asserted-by":"publisher","first-page":"719","DOI":"10.5664\/jcsm.2276","article-title":"Sleep abnormalities in chronic fatigue syndrome\/myalgic encephalomyelitis: a review","volume":"8","author":"Jackson","year":"2012","journal-title":"J Clin Sleep Med."},{"key":"B65","first-page":"912","article-title":"Sleep quality in Lyme disease","volume":"18","author":"Greenberg","year":"1995","journal-title":"Sleep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: implications for clinical management","volume":"17","author":"Charles","year":"2018","journal-title":"Lancet Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","article-title":"Targeting calcitonin gene-related peptide: a new era in migraine therapy","volume":"394","author":"Charles","year":"2019","journal-title":"Lancet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphys.2018.01249","article-title":"The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects","volume":"9","author":"Kee","year":"2018","journal-title":"Front Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","article-title":"CGRP receptors in the control of pain and inflammation","volume":"9","author":"Benemei","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10194-005-0153-6","article-title":"CGRP and migraine: neurogenic inflammation revisited","volume":"6","author":"Geppetti","year":"2005","journal-title":"J Headache Pain."},{"key":"B71","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bbi.2011.02.007","article-title":"Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells","volume":"25","author":"Huang","year":"2011","journal-title":"Brain Behav Immun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies","volume":"117","author":"Goadsby","year":"1994","journal-title":"Brain."},{"key":"B73","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12879-019-4452-y","article-title":"Cognitive impairments in patients with persistent symptoms attributed to Lyme disease","volume":"19","author":"Berende","year":"2019","journal-title":"BMC Infect Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease: do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/arclin\/acy051","article-title":"Cognitive decline in post-treatment Lyme disease syndrome","volume":"34","author":"Touradji","year":"2019","journal-title":"Arch Clin Neuropsychol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1176\/jnp.13.4.500","article-title":"A controlled study of cognitive deficits in children with chronic Lyme disease","volume":"13","author":"Tager","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/arclin\/acy083","article-title":"Neurocognition in post-treatment Lyme disease and major depressive disorder","volume":"34","author":"Keilp","year":"2019","journal-title":"Arch Clin Neuropsychol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1464-5491.2008.02655.x","article-title":"The effect of a cognitive or motor task on gait parameters of diabetic patients, with and without neuropathy","volume":"26","author":"Paul","year":"2009","journal-title":"Diabet Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.gaitpost.2014.04.209","article-title":"Correlates of dual task cost of standing balance in individuals with multiple sclerosis","volume":"40","author":"Wajda","year":"2014","journal-title":"Gait Posture."},{"key":"B80","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jns.2013.09.021","article-title":"Dual task cost of walking is related to fall risk in persons with multiple sclerosis","volume":"335","author":"Wajda","year":"2013","journal-title":"J Neurol Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/0269215515578295","article-title":"Cognitive motor intervention for gait and balance in parkinson's disease: systematic review and meta-analysis","volume":"30","author":"Wang","year":"2016","journal-title":"Clin Rehabil."},{"key":"B82","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/ene.12616","article-title":"Cognitive motor interference for gait and balance in stroke: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2015","journal-title":"Eur J Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1207\/s15324826an0601_2","article-title":"Relations among indexes of memory disturbance and depression in patients with Lyme borreliosis","volume":"6","author":"Barr","year":"1999","journal-title":"Appl Neuropsychol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1207\/s15324826an0601_3","article-title":"Psychological states and neuropsychological performances in chronic Lyme disease","volume":"6","author":"Elkins","year":"1999","journal-title":"Appl Neuropsychol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1176\/ajp.151.11.1571","article-title":"Lyme disease: a neuropsychiatric illness","volume":"151","author":"Fallon","year":"1994","journal-title":"Am J Psychiatry."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/art.24314","article-title":"Role of psychiatric comorbidity in chronic Lyme disease","volume":"59","author":"Hassett","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B87","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.psym.2018.02.004","article-title":"Depressive symptoms and suicidal ideation among symptomatic patients with a history of Lyme disease vs two comparison groups","volume":"59","author":"Doshi","year":"2018","journal-title":"Psychosomatics."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.42.7.1263","article-title":"Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients","volume":"42","author":"Kaplan","year":"1992","journal-title":"Neurology."},{"key":"B89","first-page":"1392","article-title":"Clinical and neurocognitive features of the post Lyme syndrome","volume":"23","author":"Bujak","year":"1996","journal-title":"J Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T03:24:09Z","timestamp":1667964249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":89,"alternative-id":["10.3389\/fmed.2020.00464"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00464","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"article-number":"464"}}